uniQure (NASDAQ:QURE) Earns Buy Rating from HC Wainwright
uniQure (NASDAQ:QURE – Get Free Report)‘s stock had its “buy” rating restated by investment analysts at HC Wainwright in a research note issued on Thursday,Benzinga reports. They presently have a $70.00 price target on the biotechnology company’s stock. HC Wainwright’s price target suggests a potential upside of 380.77% from the stock’s previous close. Other research […]
uniQure (NASDAQ:QURE – Get Free Report)‘s stock had its “buy” rating restated by investment analysts at HC Wainwright in a research note issued on Thursday,Benzinga reports. They presently have a $70.00 price target on the biotechnology company’s stock. HC Wainwright’s price target suggests a potential upside of 380.77% from the stock’s previous close. Other research […]
